A bright orange poison dart frog with a unique call was discovered in Donoso, Panama, and described by researchers from the Smithsonian Tropical Research Institute and the Universidad Autónoma de Chiriquí in Panama, and the Universidad de los Andes in Colombia.

Andinobates geminisae is named for Geminis Vargas, "the beloved wife of [coauthor] Marcos Ponce, for her unconditional support of his studies of Panamanian herpetology." 

Astronomers have discovered an unusual carbon-based molecule – one with a branched structure – contained within a giant gas cloud in interstellar space -  27,000 light years away. Like finding a molecular needle in a cosmic haystack, astronomers have detected radio waves emitted by isopropyl cyanide. The discovery suggests that the complex molecules needed for life may have their origins in interstellar space.

Using the Atacama Large Millimeter/submillimeter Array (ALMA), researchers studied the gaseous star-forming region Sagittarius B2.

A review in the Journal of Animal Science has found that feeding livestock diets containing genetically engineered crops has no impact on the health or productivity of those animals.

The article documents 30 years worth of livestock-feeding studies, representing more than 100 billion animals, finding that the performance and health of food-producing animals fed GE crops are comparable with those of animals fed non-GE crops. 

Since their introduction in 1996, GE feed crops have become an increasing component of livestock diets. Today, more than 95 percent of U.S. food-producing animals consume feed containing GE crops. Studies that involve feeding GE crops to livestock are used to evaluate the safety of these crops. 

Rolapitant reduces nausea and vomiting in patients receiving cisplatin-based chemotherapy, according to the results of a phase III trial presented for the first time today at the ESMO 2014 Congress in Madrid, Spain.

Afatinib, a tyrosine kinase inhibitor, significantly improved progression-free survival compared to methotrexate in patients with recurrent or metastatic squamous cell carcinoma of the head and neck after failure of platinum-based chemotherapy, the results of a phase III trial presented at the ESMO 2014 Congress in Madrid show.

The Lux-Head&Neck 1 trial showed that patients who received treatment with 40 mg/day oral afatinib had a 20% reduction in risk of progression or death compared to patients who received methotrexate, with a median progression-free survival of 2.6 months. 

The public is not aware of this, but academic science is more like a small business than being part of a vast university structure. An investigator is the business owner and the researchers are independent contractors, augmented by graduate students who go to the school.

In that sort of environment, where the life and death of the business is determined by beating other labs for a finite pool of money, while the government spends billions to try and increase the number of competitors who want to be in government-funded academia rather than the private sector, competitive instincts run high.

Sharing data either dilutes the strength of a research group or it allows a competitor to have a shortcut that another lab funded.  Lose-lose.